| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0072-9752(07)01714-9 |
| P698 | PubMed publication ID | 18631827 |
| P2093 | author name string | Allan C Skanes | |
| George J Klein | |||
| Raymond Yee | |||
| Lorne J Gula | |||
| Andrew D Krahn | |||
| Paul A Gould | |||
| P2860 | cites work | Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | Q28208692 |
| Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study | Q32055138 | ||
| Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. | Q33144644 | ||
| Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation | Q33144699 | ||
| New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. | Q33544351 | ||
| Lateralizing value of Todd's palsy in patients with epilepsy | Q35639564 | ||
| Evaluation and outcome of emergency room patients with transient loss of consciousness | Q48925781 | ||
| Syncope | Q73299382 | ||
| ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation | Q74505542 | ||
| Frequency of neurologic complications following carotid sinus massage | Q74597044 | ||
| Accurate diagnosis of convulsive syncope: role of an implantable subcutaneous ECG monitor | Q33144766 | ||
| Usefulness of tilt test-induced patterns of heart rate and blood pressure using a two-stage protocol with glyceryl trinitrate provocation in patients with syncope of unknown origin | Q33144994 | ||
| Indications, methodology, and classification of results of tilt-table testing | Q33145112 | ||
| A review of pathophysiology and therapy of patients with vasovagal syncope | Q33145280 | ||
| Misdiagnosis of epilepsy: many seizure-like attacks have a cardiovascular cause | Q33145603 | ||
| The normal response to prolonged passive head up tilt testing | Q33145829 | ||
| The elusive pathophysiology of neurally mediated syncope | Q33145948 | ||
| Predictive value of presyncope in patients monitored for assessment of syncope | Q33146340 | ||
| Diagnostic value of history in patients with syncope with or without heart disease | Q33146450 | ||
| Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy | Q33146536 | ||
| Guidelines on management (diagnosis and treatment) of syncope. | Q33146619 | ||
| Diagnostic patterns and temporal trends in the evaluation of adult patients hospitalized with syncope | Q33146676 | ||
| Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study | Q33146717 | ||
| Prospective evaluation of patients with syncope: a population-based study | Q33146759 | ||
| Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope | Q33146845 | ||
| Low yield of rule-out myocardial infarction protocol in patients presenting with syncope | Q33146858 | ||
| Mechanism of syncope in patients with bundle branch block and negative electrophysiological test | Q33146969 | ||
| Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE). | Q33147006 | ||
| Predicting the outcome of patients with unexplained syncope undergoing prolonged monitoring | Q33147459 | ||
| Historical criteria that distinguish syncope from seizures | Q33147868 | ||
| Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients' well-being | Q33147928 | ||
| Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study | Q33148062 | ||
| Incidence and prognosis of syncope | Q33148118 | ||
| Head-up tilt test with clomipramine challenge in vasovagal syndrome--a new tilt testing protocol | Q33148739 | ||
| Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans. | Q33148783 | ||
| A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope | Q33149167 | ||
| Evaluation and management of the patient with syncope | Q33150067 | ||
| External loop recorders: determinants of diagnostic yield in patients with syncope | Q33151269 | ||
| Neurocardiogenic syncope | Q33151649 | ||
| Pathophysiology of syncope | Q33151923 | ||
| Diagnostic value of history taking in reflex syncope | Q33151929 | ||
| The use of monitoring strategies in patients with unexplained syncope--role of the external and implantable loop recorder | Q33151932 | ||
| Tilt training for recurrent neurocardiogenic syncope: effectiveness, patient compliance, and scheduling the frequency of training sessions | Q33152081 | ||
| Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial | Q33152341 | ||
| Clinical practice. Neurocardiogenic syncope | Q33152418 | ||
| Neurocardiogenic syncope and related disorders of orthostatic intolerance | Q33152767 | ||
| A randomised prospective comparison of three protocols for head-up tilt testing and carotid sinus massage | Q33152903 | ||
| Arousal elicits exaggerated inhibition of sympathetic nerve activity in phobic syncope patients | Q33154956 | ||
| Methodology of head-up tilt testing in patients with unexplained syncope | Q33157984 | ||
| Cardiac loop ECG recording: a new noninvasive diagnostic test in recurrent syncope | Q33161798 | ||
| Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope | Q33162830 | ||
| The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia | Q33165688 | ||
| Head-up tilt: a useful test for investigating unexplained syncope | Q33168914 | ||
| Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope | Q33168936 | ||
| Detection of arrhythmias: use of a patient-activated ambulatory electrocardiogram device with a solid-state memory loop | Q33169710 | ||
| Symptomatic "isolated" carotid sinus hypersensitivity: natural history and results of treatment with anticholinergic drugs or pacemaker | Q33170072 | ||
| Syncope of unknown origin. The need for a more cost-effective approach to its diagnosis evaluation | Q33172930 | ||
| A prospective evaluation and follow-up of patients with syncope | Q33172994 | ||
| Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope | Q33173635 | ||
| Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope | Q33173658 | ||
| Electrophysiological testing. The final court of appeal for diagnosis of syncope? | Q33173674 | ||
| The Etiology of Syncope in Patients With Negative Tilt Table and Electrophysiological Testing | Q33173697 | ||
| Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope | Q33173817 | ||
| Syncope: a videometric analysis of 56 episodes of transient cerebral hypoxia | Q33174069 | ||
| A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt | Q33174275 | ||
| Evaluation of edrophonium as a provocative agent for vasovagal syncope during head-up tilt-table testing | Q33174291 | ||
| Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope | Q33174321 | ||
| Use of the signal-averaged electrocardiogram for predicting inducible ventricular tachycardia in patients with unexplained syncope: relation to clinical variables in a multivariate analysis | Q33174325 | ||
| Adenosine: potential modulator for vasovagal syncope | Q33174781 | ||
| Tilt table testing for assessing syncope. American College of Cardiology | Q33174782 | ||
| Echocardiography in the evaluation of patients with syncope | Q33174807 | ||
| High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias | Q33174998 | ||
| The capnography-tilt test for the diagnosis of hyperventilation syncope | Q33175067 | ||
| Sublingual nitrates during head-up tilt testing for the diagnosis of vasovagal syncope | Q33175162 | ||
| Diagnosing syncope. Part 1: Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians | Q33175214 | ||
| Diagnosing syncope. Part 2: Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians | Q33175246 | ||
| Maturation of the sensed electrogram amplitude over time in a new subcutaneous implantable loop recorder | Q33175262 | ||
| The postural orthostatic tachycardia syndrome: a neurocardiogenic variant identified during head-up tilt table testing | Q33175356 | ||
| Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope | Q33175402 | ||
| Midodrine: a role in the management of neurocardiogenic syncope. | Q33175537 | ||
| Final results from a pilot study with an implantable loop recorder to determine the etiology of syncope in patients with negative noninvasive and invasive testing | Q33175701 | ||
| Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators | Q33175934 | ||
| P304 | page(s) | 247-263 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Handbook of clinical neurology / edited by P.J. Vinken and G.W. Bruyn | Q26842295 |
| P1476 | title | Syncope | |
| P478 | volume | 90 |
Search more.